Konstantinos Mavrommatis

Title: Konstantinos Mavrommatis: Innovator in Protein Modulation

Introduction

Konstantinos Mavrommatis is a notable inventor based in Concord, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein modulation. With a total of 2 patents, his work focuses on innovative methods that enhance our understanding of cellular signaling.

Latest Patents

Mavrommatis's latest patents include compositions and methods involving antibodies that specifically bind to signal regulatory protein-α (SIRPα). These inventions aim to modulate the activity of SIRPα, providing new avenues for therapeutic applications. His patents are titled "SIRP-α binding proteins and methods of use thereof," which detail the compositions and uses of these antibodies.

Career Highlights

Currently, Konstantinos Mavrommatis is associated with Celgene Corporation, where he continues to advance his research in protein interactions and their implications in disease treatment. His work has garnered attention for its potential impact on therapeutic strategies.

Collaborations

Mavrommatis collaborates with esteemed colleagues, including Mahan Abbasian and Henry Chan, who contribute to his research endeavors and help drive innovation in the field.

Conclusion

Konstantinos Mavrommatis exemplifies the spirit of innovation in biotechnology through his patents and research. His contributions to the understanding of protein modulation are paving the way for future advancements in therapeutic applications.